Pedal Acceleration Time (PAT) as a Measure of Foot Perfusion
PAT
1 other identifier
observational
50
0 countries
N/A
Brief Summary
To identify a correlation between Toe Brachial pressure Index (TBPI) and Acceleration time of the pedal vessels. The aim would then to use this data to design a clinical study assessing the relationship between PAT and wound healing in patients with PAD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2023
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 27, 2022
CompletedFirst Posted
Study publicly available on registry
August 23, 2023
CompletedStudy Start
First participant enrolled
October 4, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 10, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 3, 2024
CompletedAugust 23, 2023
August 1, 2023
2 months
May 27, 2022
August 22, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Foot Perfusion.
ankle arterial acceleration time versus toe pressure (mmHg) Manual blood pressures of at the toe (mmHg) will also be measured from all participants, where technically possible.
1 measure
Study Arms (2)
Critical Limb Threatening Ischaemia
Patients presenting with Critical Limb Threatening Ischaemia
Non-limb threatening peripheral vascular disease
Patients presenting with non-limb threatening peripheral vascular disease
Eligibility Criteria
patients will be identified who attend the vascular clinic at the Royal Liverpool Hospital. The first 30 patients with critical limb threatening ischaemia (CLTI) that are identified and consent for the study will be recruited. Similarly the first 20 patients who have symptoms suggestive of non-critical, peripheral arterial disease such as intermittent claudication will be recruited.
You may qualify if:
- \. Male/Female 2. Adults aged 18 and above 3. Willing to provide written, informed consent 4. Referred into the vascular service with symptoms or confirmed PVD/CLTI
You may not qualify if:
- Referral not indicative of PVD
- Occlusion of vessels/no visible flow at the site of interest
- Amputation of the limb
- Tissue loss preventing assessment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 27, 2022
First Posted
August 23, 2023
Study Start
October 4, 2023
Primary Completion
December 10, 2023
Study Completion
December 3, 2024
Last Updated
August 23, 2023
Record last verified: 2023-08